Literature DB >> 16869742

Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.

S Ganesan1, A L Richardson, Z C Wang, J D Iglehart, A Miron, J Feunteun, D Silver, D M Livingston.   

Abstract

As a clinical entity, breast cancer appears to be a series of subforms, each with a relatively specific molecular phenotype. Among the characteristics that differentiate these subforms are sex hormone receptor expression, HER2 expression, p53 mutation, high-grade histopathology, and particular gene expression array patterns. Sporadic basal-like breast cancer is one such form. It is a relatively common, high-grade, hormone receptor and HER2-expression-negative, p53 mutation-bearing tumor and is particularly lethal. Although wild type for BRCA1, it is a sporadic phenocopy of most cases of BRCA1(/) breast cancer. Not only do the cells of the two tumors resemble one another with respect to the above-noted characteristics, they also share a defect in the maintenance of an intact, inactive X chromosome (Xi). Other high-grade and most low-grade tumors are rarely defective at Xi. This evidence suggests that an Xi defect contributes to the evolution of both sporadic and BRCA1(/) basal-like breast tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16869742     DOI: 10.1101/sqb.2005.70.045

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  8 in total

1.  X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations.

Authors:  Yin Shen; Youko Matsuno; Shaun D Fouse; Nagesh Rao; Sierra Root; Renhe Xu; Matteo Pellegrini; Arthur D Riggs; Guoping Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

2.  Variations of X chromosome inactivation occur in early passages of female human embryonic stem cells.

Authors:  Tamar Dvash; Neta Lavon; Guoping Fan
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

3.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

4.  Dysregulation of X chromosome inactivation in high grade ovarian serous adenocarcinoma.

Authors:  Jun Kang; Hee Jin Lee; Jiyoung Kim; Jae Jun Lee; Lee-so Maeng
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

5.  X chromosome inactivation in human parthenogenetic embryonic stem cells following prolonged passaging.

Authors:  Quan Qi; Chenhui Ding; Pingping Hong; Gang Yang; Yanxin Xie; Jing Wang; Sunxing Huang; Ke He; Canquan Zhou
Journal:  Int J Mol Med       Date:  2014-12-18       Impact factor: 4.101

6.  Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.

Authors:  Jun Kang; Hee Jin Lee; Sun-Young Jun; Eun Su Park; Lee-So Maeng
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

7.  Haploid genomes illustrate epigenetic constraints and gene dosage effects in mammals.

Authors:  Martin Leeb; Anton Wutz
Journal:  Epigenetics Chromatin       Date:  2013-12-05       Impact factor: 4.954

8.  Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.

Authors:  Henry J Henderson; Balasubramanyam Karanam; Rajeev Samant; Komal Vig; Shree R Singh; Clayton Yates; Deepa Bedi
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.